-
Artemisinin Blocks Ferroptosis to Preserve Cognition in T2DM
2026-05-03
Wang et al. (2024) demonstrate that artemisinin mitigates cognitive impairment in type 2 diabetic mice by activating Nrf2 and inhibiting ferroptosis in hippocampal neurons. The study provides mechanistic clarity on the link between oxidative neuronal death and diabetic cognitive decline, and validates established ferroptosis inducers as essential research tools.
-
CFTRinh-172: Advancing Mechanistic Insight in CFTR Inhibitio
2026-05-02
Explore how CFTRinh-172 enables next-generation CFTR research by bridging mechanistic understanding with translational strategy, drawing on recent discoveries in epithelial cell signaling. This thought-leadership article provides protocol-ready guidance, evidence-labeled recommendations, and a forward-looking perspective for cystic fibrosis and secretory disease researchers.
-
Oxaliplatin in Cancer Immunobiology: Beyond Chemotherapy
2026-05-01
Explore Oxaliplatin’s dual role as a platinum-based chemotherapeutic agent and a modulator of tumor immune microenvironments. This article reveals new translational insights for advanced cancer research and therapy.
-
CD44-Mediated NADPH Rewiring: Targetable Dependency in IDH-M
2026-05-01
This study reveals that CD44 upregulation is critical for sustaining the abnormal metabolism in IDH-mutant acute myeloid leukemia by promoting NADPH generation and (R)-2-hydroxyglutarate production. Targeting CD44-mediated metabolic rewiring, in combination with IDH2 inhibition, emerges as a promising strategy to overcome resistance and enhance therapeutic efficacy in hematologic malignancies with IDH mutations.
-
InstaBlue Protein Stain Solution: Rapid Coomassie Staining
2026-04-30
InstaBlue Protein Stain Solution enables ultra-fast, sensitive protein visualization in polyacrylamide gels without hazardous reagents or complex workflows. This Coomassie Brilliant Blue protein stain detects as little as 5 ng protein per band in under five minutes and is fully mass spectrometry compatible. Its methanol- and acetic acid-free formulation preserves protein integrity for advanced biomedical research.
-
CFTRinh-172: Applied Workflows for Precision CFTR Inhibition
2026-04-30
CFTRinh-172 enables researchers to dissect epithelial chloride channel dynamics with exceptional specificity and rapid inhibition kinetics. This guide details integrated workflows, troubleshooting strategies, and experimental insights—empowering cystic fibrosis and secretory disorder research with data-driven, reproducible protocols.
-
Enhanced ECL Chemiluminescent Substrate Detection Kit in Pro
2026-04-29
The ECL Chemiluminescent Substrate Detection Kit (Enhanced) delivers ultra-sensitive, low-background detection for western blot chemiluminescence workflows, streamlining protein immunodetection down to low-picogram targets. Its robust signal duration and plug-and-play protocol empower researchers tackling challenging antibody assays in neuroinflammation and beyond.
-
SHC-1 Inhibition Modulates CFTR Trafficking in Epithelial Ce
2026-04-29
This study defines the conserved role of the SHC-1 adaptor in CFTR internalization and plasma membrane abundance across multiple epithelial cell models. By dissecting the MAPK/SHC-1 signaling axis, the work clarifies cell-type-specific responses to SHC-1 inhibition and offers mechanistic insight for cystic fibrosis and secretory disease research.
-
Baicalin Restores Visual Plasticity in Adult Amblyopic Mice
2026-04-28
This study demonstrates that baicalin reactivates ocular dominance plasticity (ODP) and restores vision in adult mice with amblyopia. By reducing cortical GABAergic inhibition, baicalin uniquely enables functional visual recovery, offering new directions for pharmacological intervention in adult neuroplasticity.
-
Merimepodib (VX-497): Applied Protocols for Viral & Immune S
2026-04-28
Merimepodib (VX-497) is a potent, selective IMPDH inhibitor with broad-spectrum applications in antiviral, immunology, and cancer research. Explore lab-validated workflows, troubleshooting strategies, and experimental advantages—direct from recent mechanistic discoveries and APExBIO’s rigorous product standards.
-
AICAR and AMPK: Translating Immunometabolic Insights to Inno
2026-04-27
This thought-leadership article examines the multifaceted role of AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) in driving translational breakthroughs across energy metabolism regulation, inflammation inhibition, and metabolic disease research. By integrating state-of-the-art mechanistic findings—most notably the recent elucidation of AMPK's role in modulating M1 macrophage polarization via JAK2/STAT3 signaling in obesity-related asthma—with protocol guidance and strategic market context, this piece empowers translational researchers to transcend conventional product listings and unlock the full scientific and clinical potential of AMPK pathway modulation.
-
Dextrose (D-glucose) in Glucose Metabolism Research: Protoco
2026-04-27
Dextrose (D-glucose) is the gold-standard substrate for probing glucose metabolism, immunometabolic rewiring, and hypoxia adaptation in cutting-edge cellular research. This article integrates leading evidence with detailed protocols, troubleshooting tips, and advanced use-cases to maximize scientific impact and reproducibility.
-
Polybrene (Hexadimethrine Bromide) 10 mg/mL: Reliable Enhanc
2026-04-26
This article explores common laboratory challenges in gene delivery, transfection, and functional assays, and demonstrates how Polybrene (Hexadimethrine Bromide) 10 mg/mL (SKU K2701) offers reliable, data-driven solutions. With evidence-based recommendations and scenario-driven guidance, researchers can optimize assay sensitivity and reproducibility using this benchmark reagent from APExBIO.
-
FBXO22 Ligand Discovery Expands E3 Ligase Toolkit for TPD
2026-04-25
This study identifies potent chemical probes—including AHPC(Me)-C6-NH2 and 2-pyridinecarboxaldehyde (2-PCA)—that enable selective recruitment and degradation of the E3 ligase FBXO22. These findings broaden the ligandable E3 ligase landscape for targeted protein degradation strategies, with direct implications for cancer biology and next-generation PROTAC design.
-
Diphenyleneiodonium Chloride: Translational Leverage in Redo
2026-04-24
Explore how Diphenyleneiodonium chloride (DPI) advances the frontiers of redox biology and cAMP signaling research, providing mechanistic insight and strategic guidance for translational scientists. This article bridges core principles of oxidative stress response with practical workflow recommendations, highlighting DPI’s dual utility as both a redox enzyme function probe and a cAMP signaling modulator. It offers a critical evaluation of DPI’s performance, positioning APExBIO’s DPI as a pivotal tool for robust, reproducible experimental design and future clinical translation.